First, the RNA-Seq results indicated that, in addition to Fto overexpression in diabetes, Mettl3 was slightly downregulated, suggesting that this writer may also contribute to reduced m6A in diabetes. The gene discussed is METTL3; the disease is diabetes mellitus.